Filing Details
- Accession Number:
- 0001062993-22-014816
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-13 17:44:07
- Reporting Period:
- 2022-06-09
- Accepted Time:
- 2022-06-13 17:44:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1661181 | Organogenesis Holdings Inc. | ORGO | Biological Products, (No Disgnostic Substances) (2836) | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1074084 | Albert Erani | C/O Rugby Realty Co., Inc. 300 Lighting Way, Ste 210 Secaucus NJ 07094 | No | No | Yes | No | |
1757452 | Gn 2016 Organo 10-Year Grat U/A/D September 30, 2016 | 35 Sawgrass Drive Bellport NY 11713 | No | No | Yes | No | |
1760685 | Dennis Erani | 6000 Island Boulevard Apt. 2502 Aventura FL 33160 | No | No | Yes | No | |
1900525 | Red Holdings, Llc | C/O Rugby Realty Co., Inc. 300 Lighting Way, Ste 210 Secaucus NJ 07094 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Disposition | 2022-06-09 | 331 | $5.30 | 59,277,696 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2022-06-13 | 29,669 | $4.89 | 59,248,027 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.30 to $5.31, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $4.83 to $4.95, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
- Reflects the total number of securities held by the Group. Only Albert Erani has a pecuniary interest in the shares being sold pursuant to this Form 4. None of the other members of the Group has a pecuniary interest in the shares being sold pursuant to this Form 4.